Genomic Profiling of my Pancreatic Cancer Gave me a New Lease on Life
When standard treatment did not work for Roy Vinke’s pancreatic cancer, he had genomic profiling done. A mutation was found, changing his treatment plan.
When standard treatment did not work for Roy Vinke’s pancreatic cancer, he had genomic profiling done. A mutation was found, changing his treatment plan.
After a pancreatic cancer diagnosis, former basketball coach and GM Rob Babcock realized his best chance was with clinical trials.
Randall Swan did his homework on the best treatments and clinical trial options in order to do battle with pancreatic cancer.
Dr. Paul Silverstein knew that he needed genomic testing, immunotherapy, and a clinical trial in his battle with pancreatic cancer.
After Whipple surgery and chemoradiation for pancreatic cancer, Susan Zbacnik had molecular profiling, genetic testing, and joined vaccine clinical trial.
Kathleen Dowell was worried that her pancreatic cancer treatment would not work so she enrolled in a pancreatic cancer vaccine trial.
Pat Theobald lost her mother to pancreatic cancer, so when she received the same diagnosis she knew to start treatment with a clinical trial.
Richard Valdes has alternated standard pancreatic cancer treatments with clinical trials of immunotherapy and a pancreatic vaccine during his treatment.
Larry Clark describes how pancreatic cancer changed his retirement. He has pursued clinical trials as he faces recurring pancreatic cancer.
Judith Goldring outlines her treatments for pancreatic cancer using a series of clinical trials, as her cancer progresses.